Home › Funds › Ensign Peak Advisors, Inc › JNJ

Ensign Peak Advisors, Inc position in JNJ

JOHNSON & JOHNSON · Health Care

Ensign Peak Advisors, Inc reported holding 2,000,168 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$529.5M, representing 0.87% of its reported portfolio and ranking #16 among its reported holdings. Ensign Peak Advisors, Inc has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.00M sh
Reported value held$529.52M
Portfolio Weight0.87%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Ensign Peak Advisors, Inc's JNJ position evolved

Ensign Peak Advisors, Inc first disclosed a stake in JNJ in Q3 2023 at 3,090,682 shares (US$481.4M). The position peaked in Q3 2026 at 2,000,168 shares, worth US$529.5M. Across 13 filings, Ensign Peak Advisors, Inc increased the stake 3 time(s), trimmed it 9 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,000,168 shares valued at US$529.5M — a reduction of -64,478 shares quarter over quarter.. Notable position changes include a 25% trim in Q4 2023 (shares rose 1% over the following quarter), a 40% increase in Q1 2025 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.09M $481.37M New
Q4 2023 2.31M $361.72M Reduce
Q1 2024 1.97M $312.03M Reduce
Q2 2024 1.85M $270.99M Reduce
Q3 2024 1.82M $295.63M Reduce
Q4 2024 1.77M $255.69M Reduce
Q1 2025 2.48M $410.68M Add
Q2 2025 2.54M $387.37M Add
Q3 2025 2.48M $459.53M Reduce
Q4 2025 2.13M $439.98M Reduce
Q1 2026 1.97M $480.51M Reduce
Q2 2026 2.06M $524.36M Add
Q3 2026 2.00M $529.52M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Ensign Peak Advisors, Inc held JNJ?

Ensign Peak Advisors, Inc has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Ensign Peak Advisors, Inc's current position in JNJ?

As of Q3 2026, Ensign Peak Advisors, Inc holds 2.00M shares of JNJ (JOHNSON & JOHNSON), valued at $529.52M, representing 0.87% of its reported portfolio and ranking #16.

Has Ensign Peak Advisors, Inc been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Ensign Peak Advisors, Inc reduced its position in JNJ. The position peaked in Q3 2026 at 2.00M shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.